| Skin Cancer |
1 |
1 |
| Melanoma |
0 |
1 |
| Plantar |
0 |
0.93 |
| Biopsy |
0 |
0.19 |
| Metastasis |
0 |
0.15 |
| Cancer |
0 |
0.13 |
| Cutaneous Melanoma |
0 |
0.13 |
| Dermoscopy |
0 |
0.13 |
| Epidemiology |
0 |
0.13 |
| Palmar |
0 |
0.13 |
| Pigmentation |
0 |
0.13 |
| Distant Metastasis |
0 |
0.09 |
| Health Insurance |
0 |
0.09 |
| Tinea Nigra |
0 |
0.09 |
| Alaska |
0 |
0.06 |
| Atopic Dermatitis |
0 |
0.06 |
| Dermatitis |
0 |
0.06 |
| Dermatophytosis |
0 |
0.06 |
| Fungal Infection |
0 |
0.06 |
| Gland |
0 |
0.06 |
| Hand |
0 |
0.06 |
| Health Care Inequities |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Laugier-Hunziker Syndrome |
0 |
0.06 |
| New York |
0 |
0.06 |
| Pain |
0 |
0.06 |
| Pedal |
0 |
0.06 |
| Peutz-Jeghers Syndrome |
0 |
0.06 |
| Postinflammatory Hyperpigmentation |
0 |
0.06 |
| Revenue and Practice Management |
0 |
0.06 |
| Skin and Soft Tissue Infection |
0 |
0.06 |
| Texas |
0 |
0.06 |
| Uninsured |
0 |
0.06 |